Matthew Mollan

Matthew Mollan, Ph.D., CEO of Experic, has over 30 years of leadership in pharmaceutical development, manufacturing, and clinical supply. He previously led operations at Catalent, Aptuit, Pfizer, and Warner-Lambert/Parke-Davis. He holds a Ph.D. in Pharmaceutical Science and a B.S. in Pharmacy from Rutgers University.

Articles by Matthew Mollan

Drug tablet and pill rotary press machine in in the lab ore medicine manufacturing factory health and hospital background concept. Рharmaceutical laboratory. | Image Credit: ©Dr.Bakl -stock.adobe.com

CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing

ByMatthew Mollan,Adam Covitt

November 6th 2026

Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.

Matthew Mollan

Articles by Matthew Mollan

CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing

Latest Updated Articles

Trending on Pharmaceutical Technology

Improving Oral Peptide Delivery Through Structural Modifications

Drapeau’s AI Deep Dive: The Price of Acceptance in Regulated AI

AAPS PharmSci 360: How USP Is Tackling the Novel Excipient Roadblock

PharmTech AI Pulse Check: AI Policies Become Regulators' Inspection Yardstick

Supply Chain Excellence Through Just-in-Time Manufacturing